IRCT138812042976N2Other2 期
The comparison between Beclomethason Dipropionate and Fluticasone Propionate in 6-17 year old patients with moderate asthma
Zanjan University Of Medical Science0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- Other
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6 years 至 16 years（—）
- 性别
- All
入选标准
- •Patients with symptoms of cough and wheezing at night and after exercise and FEV1 between 60-80% were included in the study. Patients with other known causes of wheezing such as cystic fibrosis and heart disorders were excluded from entry into study. None of patients had been receiving inhaled corticosteroids prior the study.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Trial of Beclomethasone dipropionate versus Budesonide inhaler therapy in mild persistent asthma in childreCTRI/2013/03/003495A85
已完成
2 期
assessment of applying beclomethasone spray and fluticasone spray on endotracheal tube cuff on postoperative sore throatRelation of applying beclomethasone spray and fluticasone spray on endotracheal tube cuff with postoperative sore throat in patient with surgery.Acute pharyngitis, unspecifiedIRCT2013012812007N2Kerman University of Medical Sciences90
进行中（未招募）
1 期
Effect of fixed combination of beclomethasone dipropionate/formoterol fumarate (BDP/FF), as reliever, upon exhaled nitric oxide in asthma. FENOMENO study (Fractional Exhaled Nitric Oxide-Multiple Expiration flow of NO). A single-centre, placebo controlled, randomized, double blind, cross-over study - FenomenoModerate asthmaMedDRA version: 9.1 Level: LLT Classification code 10003553 Term: AsthmaEUCTR2007-004377-26-GBChiesi Farmaceutici S.p.A.20
进行中（未招募）
1 期
A research study to compare two formulations of beclometasone/formoterol pMDI on respiratory system.Persistent asthmaMedDRA version: 20.0 Level: PT Classification code 10003553 Term: Asthma System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2018-000353-50-GBCHIESI FARMACEUTICI S.p.A24
进行中（未招募）
不适用
Efficacy and safety of Beclomethasone dipropionate, gastro-resistant, prolonged release tablets (CHF1514) compared to oral prednisone, in a 8-week treatment period, in patients with active ulcerative colitis. An international, multicentre, randomized, double blind, parallel group study. - Beta studylcerative colitis extending proximally beyond the rectum.MedDRA version: 9.1Level: LLTClassification code 10045365Term: Ulcerative colitisEUCTR2006-004230-32-BECHIESI Farmaceutici S.p.A.300